Trademark: 88482091
Status Date
Monday, January 11, 2021
Filing Date
Thursday, June 20, 2019
Published for Opposition
Tuesday, October 15, 2019
Abandoned Date
Monday, January 11, 2021
5 Exosomes from engineered autologous mesenchymal stem cells for the treatment of autoimmune disorders and cancer
44 Cell-derived therapy services involving use of exosomes for the treatment of autoimmune disorders and cancer
Jan 11, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 11, 2021
Abandonment - No Use Statement Filed
May 29, 2020
Notice Of Approval Of Extension Request E-Mailed
May 27, 2020
Extension 1 Granted
May 27, 2020
Extension 1 Filed
May 27, 2020
Teas Extension Received
Dec 10, 2019
Noa E-Mailed - Sou Required From Applicant
Oct 15, 2019
Official Gazette Publication Confirmation E-Mailed
Oct 15, 2019
Published For Opposition
Sep 25, 2019
Notification Of Notice Of Publication E-Mailed
Sep 9, 2019
Approved For Pub - Principal Register
Sep 6, 2019
Assigned To Examiner
Jul 1, 2019
New Application Office Supplied Data Entered In Tram
Jun 24, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24